MONDAY, Oct. 25, 2021 (HealthDay News) — It’s well-known that COVID-19 pandemic restrictions pretty much quashed the 2020-2021 flu season, with influenza cases falling to never-before-seen lows in the United States. So little flu circulated, in fact, that some scientists now suspect that one of the major strains of influenzaContinue Reading

SATURDAY, Oct. 23, 2021 (HealthDay News) — Two doses of the Pfizer-BioNTech COVID-19 vaccine is nearly 91% effective in preventing symptomatic illness in young children and brings no unexpected safety issues, according to a study posted Friday by the U.S. Food and Drug Administration. Late Friday, the agency posted itsContinue Reading

FRIDAY, Oct. 22, 2021 (HealthDay News) — A lower dose of Pfizer’s coronavirus vaccine is 90.7% effective in preventing symptomatic COVID-19 in children aged 5 to 11, according to new clinical trial data from the company. The data was given to the U.S. Food and Drug Administration on Friday, andContinue Reading

THURSDAY, Oct. 21, 2021 (HealthDay News) — The Pfizer-BioNTech vaccine booster restored close to full protection against COVID-19 in a late-stage trial involving 10,000 people, the company announced Thursday. They said the booster was 95.6% effective and that they plan to submit the latest data to the U.S. Food andContinue Reading

THURSDAY, Oct. 21, 2021 (HealthDay News) — It’s a drug that’s been supported by some conservative media figures, but taking ivermectin to treat or prevent COVID-19 might land you in the hospital, a new study warns. Interest in the drug surged last summer as the highly contagious Delta variant tookContinue Reading